Only the dead have seen the end of war. ~ Plato Although history is not totally devoid of examples to the contrary, it is a rare case indeed when a free and prosperous nation sees fit to take up arms against its neighbors. We must be especially cautious, therefore, during a time when freedom is under Seeds of War, Part II originally appeared in the Daily Reckoning . The Daily Reckoning, offers a uniquely refreshing, perspective on the global economy, investing, gold, stocks and today’s markets. Its been called “the most entertaining read of the day.”

Read the original:
Seeds of War, Part II

PennyOmega.com Hot Stock News & Alerts! ________________________________________ FREE Daily Stock Alerts From PennyOmega.com ________________________________________ Saturday March 13, 2010 PennyOmega.com Stock Alert! ************************************************************** MBST, Mobile Star Corp., MBST.OB MBST has developed a coin-operated, free-standing karaoke machine. The vending machine provides a unique personal karaoke experience, and is designed by recording studio professionals. Mobile Star is easy-to-use and extremely affordable, allowing any individual to feel

Read the original post:
MBST, – PennyOmega.com Stock Alert! – Karaoke’s Popularity Brings a HUGE Distribution Agreement with Apple Industries for Mobile Star Corp.

Editor’s Note: I’m deviating from the usual Wealth Daily weekend wrap-up to present you with what I consider one of the best investing strategies around today: trading FDA decisions. Enjoy, Ian Cooper ————————————————— Very few things have such an impact on biotech stocks. FDA decisions are among the biggest factors, but given the FDA’s unpredictable nature, there’s still no such thing as a sure trade. Yet it really doesn’t matter what the FDA says. What does matter is being in the know and being in the right place at the right time. Most of us who use the FDA calendar and Phase III trial dates know one thing: The price of a biotech and pharmaceutical company will go up as the date in questions draws closer. And if you want to maximize your potential return, have any pending dates in hand at least one to three months in advance. (I should note that in some instances, you can buy a stock days in advance using conference dates.) Advertisement Thanks to a new California law… This wind energy stock could deliver gains of more than 112% in the next 4 months . Click here for more. In the case of our recent Dendreon (DNDN) trade, which produced 65% and 71% gains, we were able to profit within a day or two of a presentation at the ASCO Genitourinary Cancers Symposium. Buying ahead of this conference�— where speculators anticipated an explosive upside move�— resulted in quick gains. You see, as an FDA decision date, Phase III result date, or conference nears and people expect to hear good news, crowds of speculators and traders start coming in to buy the stock, sending the stock up. Intermune (ITMN) is a good example of this; it began popping in December 2009 ahead of FDA news: � � This happens over and over again with many biotechs and pharmaceuticals. The only key is having the information in as far in advance as you can. We also know that FDA approvals, rejections, even Phase III study results can make or break any pharmaceutical company. There have been instances where a company has lost 90% of its value… and there have been instances where a company rises 800% in a single day. But again, the key is to profiting is having the decision dates months in advance … and being well hedged. If we’re trading an FDA date months in advance, we’ll play a call option as speculators rush in. If we’re trading that same decision weeks in advance, we’ll hedge the bet with a put and a call, oftentimes successfully betting that one side will significantly outperform the other. While we’re doing our due diligence with trades two to three months out, we’ve put together a list of some biotech companies facing decisions that’ll send stock prices to the moon or kill them off. Fortunately, with options, it doesn’t matter what happens. You can profit either way. Options Trading Pit , for one, was able to profit from some of…

Read this article:
Bank Gains in This Sector Every Month

Stock-PR Reporting FREE Daily Stock Alerts From Stock-PR.com ________________________________________ Potential to Distribute Over 1,000 Karaoke Vending Units in First 12 Months NEW YORK,/CRWENEWSWIRE/ — Mobile Star Corp. (OTCBB:MBST.ob – News), a developer of coin-operated karaoke vending machines, announced today that the company has reached a preliminary distribution agreement with Apple Industries, one of North America’s premier manufacturers and distributors

Read more:
Apple Industries to Distribute Mobile Star Proprietary Karaoke Machines

Silver is often perceived to be subordinate to gold. But history clearly shows that during precious metal bull markets, silver outperforms gold. Just consider the precious metal bull market of the 1970s… Between 1970 and 1980, gold prices increased from the Brenton Woods fixed price of $35 an ounce to a high of $850. It was a 2,329% jump in the ten years. Meanwhile, silver went from about $1.50 in 1970 to over $50 an ounce in 1980�— a 3,233% increase. So far, gold has already crossed its nominal high of $850 an ounce. But silver has come nowhere near its 1980 nominal high of $50 an ounce… I think this is all about to change because… Silver is Money, Too The investment community’s general neglect of silver has historical origins. For thousands of years, silver�— not gold�— was the coin of the civilized world. One of the most complete histories on silver can be found in the book “The Silver Bonanza” by Franklin Sanders and James Blanchard. The book begins with the following quote from Milton Friedman: “The major monetary metal in history is silver, not gold.” Evidence of silver being used as money extends back to at least 4,500 years. According to “The Silver Bonanza,” the first mention of silver in the Bible is in the Old Testament in roughly 1850 BC. During King Charlemagne’s reign, silver was the only legal tender metal. Advertisement China’s Loss is Your Gain On January 1, 2010, a tiny mining company took legal control of a natural resource that today threatens the world’s fastest growing economy. And thanks to some timely reporting, our readers took early triple-digit gains in the days that followed. Today, there’s even bigger news in the works… But by the time you hear about it in the Wall Street Journal , our readers will be depositing their gains in their savings accounts. Click here to learn more. � Early colonial America also preferred silver to gold. Settlers rigged the gold-silver ratio to encourage the flow of silver into the United States. It took 15.5-16 ounces of silver to buy one ounce of gold in the rest of the world but, by decree, it took just 15 in early America. Silver was the major monetary metal for the U.S. until 1873 when it was demonetized; when this occurred, its richer cousin gold was given the sole key to the currency kingdom. Gold has received all the accolades and nearly all the ink ever since. Most “hard money” advocates will talk about gold as money for hours, as if it were religion. Lowly silver gets little or no time at all… But don’t shy away from silver. Gold always moves first in a precious metals bull market because it is seen more as money, yet silver posts better percentage returns nearly every time there is a sustained rally in gold. So why do people still ignore silver, especially as it is priced so reasonably compared to gold right now? There are five reasons that I see: The 1873 demonetization of silver occurred roughly 100 years prior to the official end of the gold standard. Investors have short memories. So when they think of …

Read the rest here:
The Gold Silver Ratio

UK Daily Mail March 12, 2010 George W Bush’s top political adviser has said he was ‘proud’ of controversial techniques such as waterboarding, which he claimed broke the will of terrorist. Karl Rove – known as the former president’s ‘brain’  – said he did not believe that the interrogation method amounted to torture. In an interview with the BBC, he claimed that waterboarding – which simulates drowning – had helped prevent terrorist attacks. ‘I’m proud that we used techniques that broke the will of these terrorists and gave us valuable information that allowed us to foil plots,’ he said.  ‘I am proud that we kept the world safer than it was by the use of these techniques. They are appropriate, they are in conformity with our international requirements and with US law.’  Read more: http://www.dailymail.co.uk/news/worldnews/article-1257437/Karl-Rove-Im-proud-using-waterboarding-break-terrorists.html#ixzz0hz0OqKRA

See the article here:
‘I’m proud of using waterboarding to break terrorists,’ declares Bush’s top political adviser

L: Doug, last time we spoke , you said quite a bit about debt, in the context of your expectation that the euro is on its way out. At the end of that conversation, you mentioned, of course, that the problem is not limited to Greece, nor the eurozone. America as a country has become a world-class debtor, and many Americans seem to think a maxed-out credit card is a reason to get a higher credit limit, not to economize. It’s like a global epidemic. Let’s talk about debt. Doug: Sure. This is a story that’s going to end very badly for a lot of people. I’ve said this before, in many different ways, but I think it’s worth saying again, because most people just don’t grok it… L: Grok. From the Martian word for “drink” and “understand.” In Heinlein’s novels, water was a critical element of Martian culture — makes sense, for a desert planet. When you grok knowledge, as when you drink water, you don’t just hold it in your mouth and spit it out. You take it into yourself, it goes into your blood, and eventually into every cell in your body; it becomes part of you. This is heavy-duty understanding… Sorry for jumping in with the spontaneous lecture. I just suspect many readers will not know the term. Doug: Or put another way, in the negative case, most people just don’t get what money really is — and what it isn’t. They take it as a given, as part of the cosmic firmament. But it’s not. A prime example of this is the mistaking of debt for money, a phenomenon David Galland pointed out in a Casey’s Daily Dispatch a few weeks ago. This is why the entire world’s monetary system today is headed for a disastrous failure. And this is absolutely inevitable. There’s no way around it. L: Why? Doug: Because you can’t use debt as money. As I’ve pointed out before , Aristotle, in the fourth century BC, was the first person to define what money …

Read more here:
How to Survive Financial Collapse Right Now

I was laid out on the couch, which I remember distinctly because my wife was yelling, “If you’re going lay down on the couch instead of doing something around the house to help me out, at least take your damned shoes off!” and I was using the remote to idly flip through the channels on Bet Against the Majority. Buy Gold. originally appeared in the Daily Reckoning . The Daily Reckoning, offers a uniquely refreshing, perspective on the global economy, investing, gold, stocks and today’s markets. Its been called “the most entertaining read of the day.”

Continue reading here:
Bet Against the Majority. Buy Gold.

Dr. Ron Paul (R-TX) isn’t one to let his opinion go unheard… especially as Congress continues approving massive amounts of debt-financed spending. From his recent Texas Straight Talk: “Last week, the House approved another increase in the national debt ceiling. This means the government can borrow $1.9 trillion more to stay afloat and avoid default. It has Ron Paul: Not Long Before the Gov’t is “Borrowing us Further Into Oblivion” originally appeared in the Daily Reckoning . The Daily Reckoning, offers a uniquely refreshing, perspective on the global economy, investing, gold, stocks and today’s markets. Its been called “the most entertaining read of the day.”

Continue reading here:
Ron Paul: Not Long Before the Gov’t is “Borrowing us Further Into Oblivion”

� � Needless to say, the new normal has turned quite a few things on their collective heads. Not surprisingly, along with this mess has come a whole new way to describe it….. From the Christian Science Monitor by Tracey D. Samuelson and Taylor Barnes entitled: Recession Slang: 10 new terms for a new economy “The recession may be technically over but its effects on our life and language are far from it. In fact, some recession words have become so ubiquitous �- staycation, for one (see below) �- that they just might be here to, ahem , stay. Recession language isn’t a new phenomenon. Thanks to the Great Depression we have terms like: Okie, dirt poor, and baloney (to mean ridiculous, not the mystery sandwich meat). Even the term “depression” has been attributed to Herbert Hoover, who is thought to have wanted to avoid using the more common, but more alarming terms “panic” or “crisis” to describe what subsequently became known as the Great Depression. So, in the spirit of trying to laugh at our collective condition, we’ve compiled a lexicon of our Top 10 favorite words birthed by the recession. Laugh, cry, and submit your favorite new-economy words in the comments below.” 10. Funemployment, n. The practice of enjoying one’s unemployment. 9. Insource, v. To do oneself what one previously paid others to do. 8. Staycation, n. Vacationing at home or near home because traveling further would be prohibitively expensive. 7. Intaxication, n. A sense of delight mingled with the perception of instant wealth that one feels upon receiving a tax refund. 5. Recessionista, n. A consumer who has historically paid big bucks to look like a million bucks and who, unwilling to quit his/her fashion habit in the face of the recession, has found alternative ways to maintain a certain standard of wardrobe. 4. Mancession, n. A recession, such as this most recent one, which hits men harder than women. 3. Povo, adj. A two-syllable “abbreviation” for poor, often with a mocking or self-defacing tone that lacks any serious derision or the class implications associated with “poor” or “poverty.” 2. Permatemp, n. The condition of being permanently employed as a temporary worker. 1. Decruited, adj. To be fired from a position one has not even started yet. �Sad but true…. Related Articles: “Funemployment” Up as The Jobless Rate Heads Higher Credit Card Companies Say “Let’s Make a Deal!” Underwater Homes Trap Borrowers into Higher Rates The Hummer Collides With the New Normal To learn more about Wealth Daily click here Advertisement Beat Big Pharma to the profits on a breakthrough that’s bigger than penicillin Right under the nose of the drug giants, this small American company has developed the genetic key to eradicating the world’s deadliest diseases — influenza, malaria, HIV, and many of the major killer cancers … Get in on this tiny stock before news of their breakthrough “cell-shock” technology gets out — and your chance at 1000 times your

Original post:
The Vocabulary of The New Normal

When health care reform passed the House in November, the vote was 220-215. Since that time…[snip]…If [our] math is correct, Democrats have only about 205 votes to pass health care reform. With four empty House seats, they will need 216. Democratic leaders will be working furiously to twist the arms of the 39 Democrats who voted “no” last time. Those who voted “NO” in November, and are likely to vote “NO” again: Dan Boren, Okla. – Boren, who has a very conservative record, will vote no, his spokesman told The Daily Caller. Allen Boyd, Fla. – His office did not… Original Article: Forum: News/Activism

See the article here:
Updated TODAY: Meet the 18 House Dems whose votes matter most on health care

Publisher’s Note: In light of last week’s failed Phase III trial of Medivation’s Alzheimer’s drug, Dimebon, I’ve asked Anavex Chairman Dr. Cameron Durrant to give us an overview of the Alzheimer’s market. Dr. Durrant has held executive positions at major global pharmaceutical companies, including Merck & Co. (NYSE: MRK), GlaxoSmithKline (NYSE: GSK), and Pharmacia Corporation, now part of Pfizer, Inc. (NYSE: PFE). Most recently, Dr. Durrant spent almost three years as Worldwide Vice President, Infectious Diseases, Global Strategic Marketing at Johnson & Johnson (NYSE: JNJ). He has also been CEO of two specialty pharmaceutical companies, PediaMed and Spherics. His article, written exclusively for Wealth Daily readers, is below… Brian Hicks ——————————————————— Alzheimer’s disease (AD) is one of the scourges of modern day health care. There are almost 30 million people worldwide diagnosed with AD�— 5 million of them in the United States. That’s the equivalent of almost the entire population of Canada and Finland, respectively. And it is projected to almost quadruple�— yes, quadruple �— by 2050, with 120 million people affected and to care for. (That’s the same population as the country of Japan, the tenth most populous country on the planet.) This patient population will equate to 1 in 85 of the world’s total population at that time… Clearly, we are sitting on a health care time bomb. There are many reasons for the increase, including an aging population globally, the baby boomer demographic, and earlier and more accurate diagnosis. Some speculate that there are other causes related to environmental issues including food and/or water chain pollutants and other toxins from our modern lifestyles. Not surprisingly, the pharmaceutical and biotech industry and academia have and continue to put a strong emphasis on developing treatments. Imagine a world where there were drugs which slowed the progression… or, better yet, stopped progression… or even helped reverse the disease and its effects, reverting people back to previous levels of functioning. Imagine, if you will, the Holy Grail�— a prevention measure that could stop people from ever developing Alzheimer’s… All of the drugs approved so far though merely address some of the symptoms. None of them alter the progression of the disease and in most cases, the beneficial effects of the drugs wear off after time. The market leader, Aricept, is co-marketed by pharma drug giant Pfizer and by the Japanese company that discovered the drug, Eisai. But Aricept goes off patent this year and the multibillion dollar sales pattern it has built will vanish quickly, as generic versions line up for approval and sale this year. There are three other marketed drugs — Exelon by Novartis; Razadyne by J+J; and Namenda by Forrest�— all off patent or coming close to it. So what do pharma behemoths like this do? They invest in their own in-house programs and/or turn to outside small companies, biotechs, start-ups, and academic-types to source innovation. That’s what Pfizer did with Medivation to get rights to Medivation’s drug, Dimebon. Unfortunately, Dimebon just failed its pivotal Phase III study, dashing hopes for patients and their caregivers and dropping about a billion dollars off the Medivation market cap. The stock collapsed by 70% within minutes of the news. More on that debacle shortly. For years, researchers considered the fact that since a buildup in the brain of a substance called amyloid�— which is deposited as plaques around neurons (brain cells)�— is associated with AD, that this could actually be the …

Here is the original post:
An Overview of the Alzheimer Drug Market